Journal: Cellular and Molecular Life Sciences
Article Title: HAS3-induced extracellular vesicles from melanoma cells stimulate IHH mediated c-Myc upregulation via the hedgehog signaling pathway in target cells
doi: 10.1007/s00018-019-03399-5
Figure Lengend Snippet: HAS3-EVs induce c-Myc and EMT by HH signaling. Protein expression of HH and EMT markers were tested in HaCaT ( a , c , e ) and WM115 cells ( b , d , f ). Both HaCaT and WM115 cells were treated with a Gli inhibitor, GANT58 and a constitutively expressing c-Myc T58A plasmid, along with HAS3-EVs. The impact of the treatments on proliferation was also tested in both HaCaT ( g ) and WM115 ( h ) cells. All the statistical significance tests were done in comparison to control. The data represent mean ± S.E. of four independent experiments. * P value < 0.05, ** P value < 0.01, *** P value < 0.001, one-way ANOVA (Tukey’s test). H3 or H3-EVs HAS3-EVs, Clsi and Myci siRNAs for claspin and c-Myc, E-cad E-cadherin, Gli-inhi or Gli Gli inhibitor
Article Snippet: Plasmid transfection was done with Lipofectamine 3000 (Invitrogen) and siRNA transfections were done with Lipofectamine RNAiMAX (Invitrogen), according to the manufacturers’ instructions. c-Myc T58A (Addgene, USA), EGFP-C1 (Clontech, USA), pcDNA, GFP-mHAS3 D216A [ ] and GFP-ΔHAS3 plasmids were used in 12 well, 6 cm and 15 cm plate formats.
Techniques: Expressing, Plasmid Preparation, Comparison, Control